8-K: Current report filing

Published on July 22, 2024

 

Exhibit 99.1

 

Pro Forma Financial Overview  

 

LTM Mar-24 Financials

 

($ in millions)   Restricted Group
(Domestic)
    International     Unrestricted
Subsidiaries1
    Consolidated  
Theatres     383       337       175       895  
Revenue   $ 2,405     $ 1,136     $ 1,269     $ 4,810  
Adj. EBITDA   $ 156     $ 55     $ 176     $ 387  
Memo                                
Revenue / Theatre   $ 6.3     $ 3.4     $ 7.2     $ 5.4  
Adj. EBITDA / Theatre   $ 0.4     $ 0.2     $ 1.0     $ 0.4  

 

Note: 361,159,031 common shares outstanding as of July 17th

 

1. Includes (i) new Unrestricted Subsidiary holding transferred theatre and intellectual property assets and (ii) Centertainment Development. AMC Theatres of UK included in International.

 

 

 

 

          (unaudited)        
    AMCEH &              
    Restricted     Unrestricted        
(In millions, except share data)   Subsidiaries     Subsidiaries     Consolidated  
ASSETS                        
Current assets:                        
Cash and cash equivalents   $ 400.9     $ 94.7     $ 495.6  
Restricted cash     23.1             23.1  
Intercompany receivables (payables)     11.3       (11.3 )      
Receivables, net     101.6       4.1       105.7  
Other current assets     81.6       34.5       116.1  
Total current assets     618.5       122.0       740.5  
Property, net     1,230.2       440.0       1,670.2  
Operating lease right-of-use assets, net     2,811.7       928.6       3,740.3  
Intangible assets, net     43.0       104.4       147.4  
Goodwill     2,342.7             2,342.7  
Other long-term assets     205.6       0.9       206.5  
Investment in subsidiary     444.3       (444.3 )      
Total assets   $ 7,696.0     $ 1,151.6     $ 8,847.6  
LIABILITIES AND STOCKHOLDERS’ DEFICIT                        
Current liabilities:                        
Accounts payable   $ 213.6     $ 43.4     $ 257.0  
Accrued expenses and other liabilities     467.5       23.1       490.6  
Deferred revenues and income     386.7       5.0       391.7  
Current maturities of corporate borrowings     20.0             20.0  
Current maturities of finance lease liabilities     6.5             6.5  
Current maturities of operating lease liabilities     383.5       163.0       546.5  
Total current liabilities     1,477.8       234.5       1,712.3  
Corporate borrowings     4,862.0             4,862.0  
Finance lease liabilities     52.0             52.0  
Operating lease liabilities     3,260.0       912.2       4,172.2  
Exhibitor services agreement     502.5             502.5  
Deferred tax liability, net     32.7             32.7  
Shareholder litigation liability                  
Other long-term liabilities     99.3       4.9       104.2  
Total liabilities     10,286.3       1,151.6       11,437.9  
Commitments and contingencies                        
Stockholders’ deficit:                        
AMC Entertainment Holdings, Inc.'s stockholders' deficit:                        
Preferred stock     0.1             0.1  
Class A common stock     5.2             5.2  
Additional paid-in capital     5,322.1             5,322.1  
Accumulated other comprehensive loss     (84.6 )           (84.6 )
Accumulated deficit     (7,833.1 )           (7,833.1 )
Total stockholders' deficit     (2,590.3 )           (2,590.3 )
Total liabilities and stockholders’ deficit   $ 7,696.0     $ 1,151.6     $ 8,847.6  

 

 

 

    Three Months Ended March 31, 2023  
    (unaudited)  
    AMCEH &              
    Restricted     Unrestricted        
(In millions)   Subsidiaries     Subsidiaries     Consolidated  
Revenues                  
Admissions   $ 382.1     $ 152.0     $ 534.1  
Food and beverage     249.8       78.9       328.7  
Other theatre     77.6       14.0       91.6  
Intercompany management services     3.2       (3.2 )      
Intercompany royalty fee     (2.3 )     2.3        
Total revenues     710.8       244.0       954.4  
Operating costs and expenses                        
Film exhibition costs     172.0       74.2       246.2  
Food and beverage costs     48.3       13.1       61.4  
Operating expense, excluding depreciation and amortization below     294.4       88.8       383.2  
Rent     150.1       55.6       205.7  
General and administrative:                        
Merger, acquisition and other costs     0.2             0.2  
Other, excluding depreciation and amortization below     72.3             72.3  
Depreciation and amortization     69.4       24.2       93.6  
Impairment of long-lived assets                  
Operating costs and expenses     806.7       255.9       1,062.6  
Operating income (loss)     (96.3 )     (11.9 )     (108.2 )
Other expense, net:                        
Other expense (income)     37.9       (0.1 )     37.8  
Interest expense:                        
Corporate borrowings     90.7             90.7  
Finance lease obligations     0.9             0.9  
Non-cash NCM exhibitor services agreement     9.5             9.5  
Investment expense (income)     2.0       (15.5 )     (13.5 )
Total other expense, net     141.0       (15.6 )     125.4  
Net earnings (loss) before income taxes     (237.3 )     3.7       (233.6 )
Income tax provision     1.9             1.9  
Net earnings (loss)   $ (239.2 )   $ 3.7     $ (235.5 )

 

Adjusted EBITDA for the unrestricted subsidiaries for three months ended March 31, 2023, was $11.1 million.

 

 

 

    Three Months Ended March 31, 2023  
    (unaudited)  
    AMCEH &              
    Restricted     Unrestricted        
    Subsidiaries     Subsidiaries     Consolidated  
Net earnings (loss)   $ (239.2 )   $ 3.7     $ (235.5 )
Other comprehensive loss:                        
Unrealized foreign currency translation adjustments     (7.7 )     0.5       (7.2 )
Pension adjustments:                        
Net gain (loss) arising during the period     (0.1 )           (0.1 )
Other comprehensive loss:     (7.8 )     0.5       (7.3 )
Total comprehensive loss   $ (247.0 )   $ 4.2     $ (242.8 )

 

 

 

    Three months ended  
    March 31, 2023  
    (unaudited)  
    AMCEH &              
    Restricted     Unrestricted        
    Subsidiaries     Subsidiaries     Consolidated  
Net loss   $ (239.2 )   $ 3.7     $ (235.5 )
Adjustments to reconcile net loss to net cash used in operating activities:                        
Depreciation and amortization     69.4       24.2       93.6  
(Gain) loss on extinguishment of debt     (65.1 )           (65.1 )
Deferred income taxes     0.6             0.6  
Impairment of long-lived assets                  
Unrealized loss (gain) on investments in Hycroft     4.6             4.6  
Amortization of net premium on corporate borrowings to interest expense     (15.2 )           (15.2 )
Amortization of deferred financing costs to interest expense     2.3             2.3  
Non-cash portion of stock-based compensation     25.9             25.9  
Gain on disposition of Saudi Cinema Company           (15.5 )     (15.5 )
Equity in loss from non-consolidated entities, net of distributions     (0.8 )     (0.3 )     (1.1 )
Landlord contributions     6.4             6.4  
Other non-cash rent benefit     (8.0 )     (1.6 )     (9.6 )
Deferred rent     (29.7 )     (8.9 )     (38.6 )
Net periodic benefit cost (income)     0.4             0.4  
Non-cash shareholder litigation expense     116.6             116.6  
Change in assets and liabilities:                        
Receivables     63.6       3.4       67.0  
Other assets     (26.8 )     (1.7 )     (28.5 )
Accounts payable     (55.0 )     (10.2 )     (65.2 )
Accrued expenses and other liabilities     (20.9 )     (0.1 )     (21.0 )
Intercompany receivables and payables     (11.3 )     11.3        
Other, net     (12.4 )     0.4       (12.0 )
Net cash used in operating activities     (195.6 )     4.7       (189.9 )
Cash flows from investing activities:                        
Capital expenditures     (41.1 )     (6.3 )     (47.4 )
Acquisition of theatre assets                  
Proceeds from disposition of Saudi Cinema Company           30.0       30.0  
Proceeds from disposition of long-term assets     0.8             0.8  
Other, net                  
Net cash used in investing activities     (40.3 )     23.7       (16.6 )
Cash flows from financing activities:                        
Repurchase of Senior Subordinated Notes due 2026     (1.7 )           (1.7 )
Repurchase of Second Lien Notes due 2026     (54.8 )           (54.8 )
Scheduled principal payments under Term Loan due 2026     (5.0 )           (5.0 )
Net proceeds from equity issuances     146.6             146.6  
Principal payments under finance lease obligations     (1.6 )           (1.6 )
Cash used to pay for deferred financing costs     (1.5 )           (1.5 )
Taxes paid for restricted unit withholdings     (13.1 )           (13.1 )
Net cash provided by (used in) financing activities     68.9             68.9  
Effect of exchange rate changes on cash and cash equivalents and restricted cash     1.9             1.9  
Net decrease in cash and cash equivalents and restricted cash     (164.1 )     28.4       (135.7 )
Cash and cash equivalents and restricted cash at beginning of period     588.1       15.7       654.4  
Cash and cash equivalents and restricted cash at end of period   $ 424.0     $ 94.7     $ 518.7  

 

 

 

 

    As of December 31, 2023  
    (unaudited)  
    AMCEH &              
    Restricted     Unrestricted        
(In millions, except share data)   Subsidiaries     Subsidiaries     Consolidated  
ASSETS                        
Current assets:                        
Cash and cash equivalents   $ 785.4     $ 98.9     $ 884.3  
Restricted cash     27.1             27.1  
Intercompany receivables (payables)     (92.5 )     92.5        
Receivables, net     193.1       10.6       203.7  
Other current assets     53.2       34.8       88.0  
Total current assets     966.3       236.8       1,203.1  
Property, net     1,153.1       407.3       1,560.4  
Operating lease right-of-use assets, net     2,649.2       895.3       3,544.5  
Intangible assets, net     42.3       104.4       146.7  
Goodwill     2,358.7             2,358.7  
Other long-term assets     194.8       1.0       195.8  
Investment in subsidiary     554.2       (554.2 )      
Total assets   $ 7,918.6     $ 1,090.6     $ 9,009.2  
LIABILITIES AND STOCKHOLDERS’ DEFICIT                        
Current liabilities:                        
Accounts payable   $ 273.0     $ 47.5     $ 320.5  
Accrued expenses and other liabilities     329.6       21.2       350.8  
Deferred revenues and income     420.2       1.6       421.8  
Current maturities of corporate borrowings     25.1             25.1  
Current maturities of finance lease liabilities     5.4             5.4  
Current maturities of operating lease liabilities     367.9       140.9       508.8  
Total current liabilities     1,421.2       211.2       1,632.4  
Corporate borrowings     4,552.3             4,552.3  
Finance lease liabilities     50.0             50.0  
Operating lease liabilities     3,125.4       875.3       4,000.7  
Exhibitor services agreement     486.6             486.6  
Deferred tax liability, net     32.4             32.4  
Shareholder litigation liability                  
Other long-term liabilities     98.6       4.1       102.7  
Total liabilities     9,766.5       1,090.6       10,857.1  
Commitments and contingencies                        
Stockholders’ deficit:                        
AMC Entertainment Holdings, Inc.'s stockholders' deficit:                        
Preferred stock                  
Class A common stock     2.6             2.6  
Additional paid-in capital     6,221.9             6,221.9  
Accumulated other comprehensive loss     (78.2 )           (78.2 )
Accumulated deficit     (7,994.2 )           (7,994.2 )
Total stockholders' deficit     (1,847.9 )           (1,847.9 )
Total liabilities and stockholders’ deficit   $ 7,918.6     $ 1,090.6     $ 9,0009.2  

 

 

 

    Twelve Months Ended December 31, 2023  
    (unaudited)  
    AMCEH &              
    Restricted     Unrestricted        
(In millions)   Subsidiaries     Subsidiaries     Consolidated  
Revenues                  
Admissions   $ 1,893.7     $ 796.8     $ 2,690.5  
Food and beverage     1,255.4       414.4       1,669.8  
Other theatre     375.1       77.2       452.3  
Intercompany management services     19.7       (19.7 )      
Intercompany royalty fee     (12.0 )     12.0        
Total revenues     3,531.9       1,280.7       4,812.6  
Operating costs and expenses                        
Film exhibition costs     888.3       402.8       1,291.1  
Food and beverage costs     246.0       69.3       315.3  
Operating expense, excluding depreciation and amortization below     1,292.4       399.1       1,691.5  
Rent     653.4       220.1       873.5  
General and administrative:                        
Merger, acquisition and other costs     1.7             1.7  
Other, excluding depreciation and amortization below     241.9             241.9  
Depreciation and amortization     275.2       89.8       365.0  
Impairment of long-lived assets     104.3       2.6       106.9  
Operating costs and expenses     3,703.2       1,183.7       4,886.9  
Operating income (loss)     (171.3 )     97.0       (74.3 )
Other expense, net:                        
Other expense (income)     (77.6 )     0.8       (76.8 )
Interest expense:                        
Corporate borrowings     369.6             369.6  
Finance lease obligations     3.7             3.7  
Non-cash NCM exhibitor services agreement     37.9             37.9  
Investment expense (income)     0.9       (16.4 )     (15.5 )
Total other expense, net     334.5       (15.6 )     318.9  
Net earnings (loss) before income taxes     (505.8 )     112.6       (393.2 )
Income tax provision     3.4             3.4  
Net earnings (loss)   $ (509.2 )   $ 112.6     $ (396.6 )

 

Adjusted EBITDA for the unrestricted subsidiaries for twelve months ended December 31, 2023, was $183.2 million.

 

 

 

    Twelve Months Ended December 31, 2023  
    (unaudited)  
    AMCEH &              
    Restricted     Unrestricted        
    Subsidiaries     Subsidiaries     Consolidated  
Net earnings (loss)   $ (509.2 )   $ 112.6     $ (396.6 )
Other comprehensive loss:                        
Unrealized foreign currency translation adjustments     (0.4 )     1.5       1.1  
Pension adjustments:                        
Net gain (loss) arising during the period     (2.0 )           (2.0 )
Other comprehensive loss:     (2.4 )     1.5       (0.9 )
Total comprehensive loss   $ (511.6 )   $ 114.1     $ (397.5 )

 

 

 

    Twelve months ended  
    December 31, 2023  
    (unaudited)  
                   
    Restricted     Unrestricted        
    Subsidiaries     Subsidiaries     Consolidated  
Net loss   $ (509.2 )   $ 112.6     $ (396.6 )
Adjustments to reconcile net loss to net cash used in operating activities:                        
Depreciation and amortization     275.2       89.8       365.0  
(Gain) loss on extinguishment of debt     (142.8 )           (142.8 )
Deferred income taxes     0.7             0.7  
Impairment of long-lived assets     104.3       2.6       106.9  
Unrealized loss (gain) on investments in Hycroft     12.6             12.6  
Amortization of net premium on corporate borrowings to interest expense     (55.6 )           (55.6 )
Amortization of deferred financing costs to interest expense     9.6             9.6  
Non-cash portion of stock-based compensation     42.5             42.5  
Gain on disposition of Saudi Cinema Company           (15.5 )     (15.5 )
Equity in loss from non-consolidated entities, net of distributions     0.1       (0.3 )     (0.2 )
Landlord contributions     22.6       1.3       23.9  
Other non-cash rent benefit     (28.7 )     (6.3 )     (35.0 )
Deferred rent     (90.2 )     (33.9 )     (124.1 )
Net periodic benefit cost (income)     1.4             1.4  
Non-cash shareholder litigation expense     99.3             99.3  
Change in assets and liabilities:                        
Receivables     (42.5 )     (3.1 )     (45.6 )
Other assets     (4.4 )     (2.3 )     (6.7 )
Accounts payable     5.4       (6.1 )     (0.7 )
Accrued expenses and other liabilities     (18.8 )     (7.9 )     (26.7 )
Intercompany receivables and payables     92.5       (92.5 )      
Other, net     (30.5 )     2.9       (27.6 )
Net cash used in operating activities     (256.5 )     41.3       (215.2 )
Cash flows from investing activities:                        
Capital expenditures     (186.9 )     (38.7 )     (225.6 )
Acquisition of theatre assets     (4.0 )           (4.0 )
Proceeds from disposition of Saudi Cinema Company           30.0       30.0  
Proceeds from disposition of long-term assets     16.5             16.5  
Other, net     3.0             3.0  
Net cash used in investing activities     (171.4 )     (8.7 )     (180.1 )
Cash flows from financing activities:                        
Repurchase of Senior Subordinated Notes due 2026     (1.7 )           (1.7 )
Repurchase of Second Lien Notes due 2026     (139.9 )           (139.9 )
Scheduled principal payments under Term Loan due 2026     (20.0 )           (20.0 )
Net proceeds from equity issuances     832.7             832.7  
Principal payments under finance lease obligations     (5.6 )           (5.6 )
Cash used to pay for deferred financing costs     (2.0 )           (2.0 )
Taxes paid for restricted unit withholdings     (14.2 )           (14.2 )
Net cash provided by (used in) financing activities     649.3             649.3  
Effect of exchange rate changes on cash and cash equivalents and restricted cash     3.0             3.0  
Net decrease in cash and cash equivalents and restricted cash     224.4       32.6       257.0  
Cash and cash equivalents and restricted cash at beginning of period     588.1       66.3       654.4  
Cash and cash equivalents and restricted cash at end of period   $ 812.5     $ 98.9     $ 911.4  

 

 

 

          (unaudited)        
    AMCEH &              
    Restricted     Unrestricted        
(In millions, except share data)   Subsidiaries     Subsidiaries     Consolidated  
ASSETS                        
Current assets:                        
Cash and cash equivalents   $ 526.0     $ 98.2     $ 624.2  
Restricted cash     36.5             36.5  
Intercompany receivables (payables)     (83.1 )     83.1        
Receivables, net     129.3       11.1       140.4  
Other current assets     77.6       34.3       111.9  
Total current assets     686.3       226.7       913.0  
Property, net     1,111.2       393.1       1,504.3  
Operating lease right-of-use assets, net     2,587.4       872.1       3,459.5  
Intangible assets, net     41.4       104.4       145.8  
Goodwill     2,322.1             2,322.1  
Other long-term assets     193.1       0.9       194.0  
Investment in subsidiary     541.8       (541.8 )      
Total assets   $ 7,483.3     $ 1,055.4     $ 8,538.7  
LIABILITIES AND STOCKHOLDERS’ DEFICIT                        
Current liabilities:                        
Accounts payable   $ 208.7     $ 41.5     $ 250.2  
Accrued expenses and other liabilities     300.3       19.2       319.5  
Deferred revenues and income     391.6       2.6       394.2  
Current maturities of corporate borrowings     25.0             25.0  
Current maturities of finance lease liabilities     5.2             5.2  
Current maturities of operating lease liabilities     368.7       140.2       508.9  
Total current liabilities     1,299.5       203.5       1,503.0  
Corporate borrowings     4,518.0             4,518.0  
Finance lease liabilities     48.0             48.0  
Operating lease liabilities     3,037.0       848.0       3,885.0  
Exhibitor services agreement     481.1             481.1  
Deferred tax liability, net     32.8             32.8  
Shareholder litigation liability                  
Other long-term liabilities     97.9       3.9       101.8  
Total liabilities     9,514.3       1,055.4       10,569.7  
Commitments and contingencies                        
Stockholders’ deficit:                        
AMC Entertainment Holdings, Inc.'s stockholders' deficit:                        
Preferred stock                  
Class A common stock     2.6             2.6  
Additional paid-in capital     6,237.7             6,237.7  
Accumulated other comprehensive loss     (113.6 )           (113.6 )
Accumulated deficit     (8,157.7 )           (8,157.7 )
Total stockholders' deficit     (2,031.0 )           (2,031.0 )
Total liabilities and stockholders’ deficit   $ 7,483.3     $ 1,055.4     $ 8,538.7  

 

 

 

    Three Months Ended March 31, 2024  
    (unaudited)  
    AMCEH &              
    Restricted     Unrestricted        
(In millions)   Subsidiaries     Subsidiaries     Consolidated  
Revenues                  
Admissions   $ 383.1     $ 147.4     $ 530.5  
Food and beverage     245.8       75.4       321.2  
Other theatre     85.2       14.5       99.7  
Intercompany management services     3.1       (3.1 )      
Intercompany royalty fee     (2.3 )     2.3        
Total revenues     714.9       236.5       951.4  
Operating costs and expenses                        
Film exhibition costs     169.9       69.4       239.3  
Food and beverage costs     49.2       13.8       63.0  
Operating expense, excluding depreciation and amortization below     303.4       90.4       393.8  
Rent     168.5       56.0       224.5  
General and administrative:                        
Merger, acquisition and other costs     (0.1 )           (0.1 )
Other, excluding depreciation and amortization below     57.7             57.7  
Depreciation and amortization     61.9       19.7       81.6  
Impairment of long-lived assets                  
Operating costs and expenses     810.5       249.3       1,059.8  
Operating income (loss)     (95.6 )     (12.8 )     (108.4 )
Other expense, net:                        
Other expense (income)     (42.5 )     (0.3 )     (42.8 )
Interest expense:                        
Corporate borrowings     91.0             91.0  
Finance lease obligations     0.9             0.9  
Non-cash NCM exhibitor services agreement     9.3             9.3  
Investment expense (income)     (4.7 )     (0.4 )     (5.1 )
Total other expense, net     54.9       (0.7 )     53.3  
Net earnings (loss) before income taxes     (149.6 )     (12.1 )     (161.7 )
Income tax provision     1.8             1.8  
Net earnings (loss)   $ (151.4 )   $ (12.1 )   $ (163.5 )

 

Adjusted EBITDA for the unrestricted subsidiaries for three months ended March 31, 2024, was $5.1 million.

 

 

 

    Three Months Ended March 31, 2024  
    (unaudited)  
    AMCEH &              
    Restricted     Unrestricted        
    Subsidiaries     Subsidiaries     Consolidated  
Net earnings (loss)   $ (151.4 )   $ (12.1 )   $ (163.5 )
Other comprehensive loss:                        
Unrealized foreign currency translation adjustments     (35.5 )     (0.3 )     (35.8 )
Pension adjustments:                        
Net gain (loss) arising during the period     0.4             0.4  
Other comprehensive loss:     (35.1 )     (0.3 )     (35.4 )
Total comprehensive loss   $ (186.5 )   $ (12.4 )   $ (198.9 )

 

 

 

    Three months ended  
    March 31, 2024  
    (unaudited)  
    AMCEH &              
    Restricted     Unrestricted        
    Subsidiaries     Subsidiaries     Consolidated  
Net loss   $ (151.4 )   $ (12.1 )   $ (163.5 )
Adjustments to reconcile net loss to net cash used in operating activities:                        
Depreciation and amortization     61.9       19.7       81.6  
(Gain) loss on extinguishment of debt     (5.8 )           (5.8 )
Deferred income taxes     0.5             0.5  
Impairment of long-lived assets                  
Unrealized loss (gain) on investments in Hycroft     1.0             1.0  
Amortization of net premium on corporate borrowings to interest expense     (11.2 )           (11.2 )
Amortization of deferred financing costs to interest expense     2.5             2.5  
Non-cash portion of stock-based compensation     4.3             4.3  
Gain on disposition of Saudi Cinema Company                  
Equity in loss from non-consolidated entities, net of distributions     (2.4 )           (2.4 )
Landlord contributions     4.6             4.6  
Other non-cash rent benefit     (10.0 )     (1.7 )     (11.7 )
Deferred rent     (13.3 )     (3.1 )     (16.4 )
Net periodic benefit cost (income)     0.7             0.7  
Non-cash shareholder litigation expense                  
Change in assets and liabilities:                        
Receivables     59.3       (0.5 )     58.8  
Other assets     (24.3 )     0.6       (23.7 )
Accounts payable     (42.1 )     (6.0 )     (48.1 )
Accrued expenses and other liabilities     (61.1 )     (1.4 )     (62.5 )
Intercompany receivables and payables     (9.4 )     9.4        
Other, net     3.3       (0.3 )     3.0  
Net cash used in operating activities     (192.9 )     4.6       (188.3 )
Cash flows from investing activities:                        
Capital expenditures     (45.2 )     (5.3 )     (50.5 )
Acquisition of theatre assets                  
Proceeds from disposition of Saudi Cinema Company                  
Proceeds from disposition of long-term assets                  
Other, net     0.5             0.5  
Net cash used in investing activities     (44.7 )     (5.3 )     (50.0 )
Cash flows from financing activities:                        
Repurchase of Senior Subordinated Notes due 2026                  
Repurchase of Second Lien Notes due 2026                  
Scheduled principal payments under Term Loan due 2026     (5.0 )           (5.0 )
Net proceeds from equity issuances     (0.5 )           (0.5 )
Principal payments under finance lease obligations     (1.2 )           (1.2 )
Cash used to pay for deferred financing costs     (0.1 )           (0.1 )
Taxes paid for restricted unit withholdings     (2.2 )           (2.2 )
Net cash provided by (used in) financing activities     (9.0 )           (9.0 )
Effect of exchange rate changes on cash and cash equivalents and restricted cash     (3.4 )           (3.4 )
Net decrease in cash and cash equivalents and restricted cash     (250.0 )     (0.7 )     (250.7 )
Cash and cash equivalents and restricted cash at beginning of period     812.5       98.9       911.4  
Cash and cash equivalents and restricted cash at end of period   $ 562.5     $ 98.2     $ 660.7